1Gaede P,Lund-Andersen H,Parving HH,et al.Effect of a multifactorial intervention on mortality in type2diabetes[J].N Engl J Med,2008,358(6):580-591.
2Ridker PM,Buring JE,Rifai N,et al.Development and validation of improved algorithms for the assessment of global cardiovascular risk in women:the Reynolds Risk Score[J].JAMA,2007,297(6):611-619.
3Nambi V,Hoogeveen RC,Chambless L,et al.Lipopro-tein-associated phospholipase A2and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities(ARIC)study[J].Stroke,2009,40(2):376-381.
9Deguchi JO,Aikawa M,Tung CH,et al.Inflammation in Atherosclerosis:visualizing matrix metalloproteinase ac-tion in macrophages in vivo[J].Circulation,2006,114(1):55-62.
10Johnson JL,Baker AH,Oka K,et al.Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2:involvement of macro-phage migration and apoptosis[J].Circulation,2006,113(20):2435-2444.
3Mosca L, Collins P, Herrington D M, et al. Hormone re?placement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Associ?ation] 1]. Circulation, 2001, 104( 4) :499-503.
4Makela R, Dastidar P,Jokela H, et al. Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase pro?moter polymorphism[J].J Clin Endocrinol Metab, 2003, 88(8) :3823-3828.
5Libby P, Ridker PM, Maseri A. Inflammation and athero?sclerosis] 1]. Circulation, 2002,105 (9) : 1135-1143.
6Bassuk 5 5, Rifai N, Ridker P M. High-sensitivity C-reac?tive protein: clinical importance[J]. Curr Probl Cardiol, 2004,29(8):439-493.
7Libby P, Ridker P M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment[J]. AmJ Med, 2004,116(suppl. 6A) :95-165.
8Kishimoto T. IL-6 from its discovery to clinical applications[J]. Int Immunol, 2010,22(5) :347-352.
9Emerging Risk Factors Collaboration, Kaptoge 5, Di An?gelantonio E, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction[J] . N EnglJ Med, 2012,367(14) :1310-1320.
10Marcondes F K, Bianchi FJ, Tanno A P. Determination of the estrous cycle phases of rats: some helpful considerations [J]. BrazJ BioI, 2002,62(4A) :609-1i14.
